a company which translates genome editing technology into a novel class of human therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To EDIT | 1D Price Change % | ||
---|---|---|---|---|
EDIT | 100% | -6.68% | ||
NTLA - EDIT | 74% Closely correlated | -3.65% | ||
CRSP - EDIT | 67% Closely correlated | -4.61% | ||
BEAM - EDIT | 66% Closely correlated | -8.55% | ||
PRME - EDIT | 54% Loosely correlated | -9.81% | ||
ALLO - EDIT | 52% Loosely correlated | -4.56% | ||
More |
Ticker / NAME | Correlation To EDIT | 1D Price Change % |
---|---|---|
EDIT | 100% | -6.68% |
EDIT (4 stocks) | 78% Closely correlated | +0.86% |
gene-based medicines (3 stocks) | 73% Closely correlated | +0.40% |
biotechnology (248 stocks) | 55% Loosely correlated | +5.56% |
drugs (265 stocks) | 53% Loosely correlated | +5.37% |
human (15 stocks) | 28% Poorly correlated | +1.59% |